dr-reddy-laboratories - Latest News on dr-reddy-laboratories | Read Breaking News on Zee News
Dr Reddy's launches insomnia drug in US; Glenmark gets FDA nod

Dr Reddy's launches insomnia drug in US; Glenmark gets FDA nod

Last Updated: Wednesday, April 16, 2014, 14:46

The company has started selling 1 mg, 2 mg and 3 mg tablets of Eszopiclone.

Dr Reddy's eyes fresh foray into Japanese market

Last Updated: Sunday, March 30, 2014, 16:13

After shrugging off its proposed joint venture with Fujifilm which was a non-starter, Dr Reddy's Laboratories Limited is back on the drawing board and is keen to make a fresh foray into the Japanese market.

Dr Reddy's Lab recalls 58,656 bottles of Lansoprazole in US

Last Updated: Thursday, March 13, 2014, 14:20

Dr Reddy's Laboratories has recalled 58,656 bottles of its heartburn drug Lansoprazole in the United States due to a microbial contamination.

Dr Reddy's launches antibiotic drug in US market

Last Updated: Wednesday, March 05, 2014, 14:53

Dr Reddy's Laboratories Ltd has launched Moxifloxacin Hydrochloride tablets in the US market for the treatment of a wide range of diseases, including pneumonia, bronchitis and skin infections.

Dr Reddy's to launch anti-blood clot drug in Canada

Last Updated: Monday, November 04, 2013, 17:41

Country's largest drug maker Dr Reddy's Laboratories is set to take its complex generic drug Fondaparinux sodium injection to Canada and two other emerging markets.

Dr Reddy's Lab Q2 profit up 69% at Rs 690 crore

Last Updated: Thursday, October 31, 2013, 15:54

Drug major Dr Reddy's Laboratories today reported a 69.41 percent increase in consolidated net profit at Rs 690.25 crore for the second quarter ended September 30.

Reddy's would infringe on Lunesta's patent: US court of appeal

Last Updated: Friday, September 27, 2013, 12:21

United States Court of Appeals for the Federal Circuit has ruled that Dr Reddy's Laboratories Ltd would infringe on the patent of Sunovion Pharmaceuticals blockbuster drug Lunesta.

Dr Reddy's Apr-Jun Net up 7% at Rs 361 cr

Last Updated: Tuesday, July 30, 2013, 16:33

Drug maker Dr Reddy's Laboratories Tuesday said its net profit rose by over seven percent to Rs 361 crore for the quarter ended June 30, primarily driven by North American revenues.

Dr Reddy’s Labs, Fujifilm call off proposed generic drug JV

Last Updated: Monday, June 03, 2013, 13:47

Though the Memorandum of Understanding for generic drugs has been cancelled, both the companies will explore partnerships in other related areas, said a statement issued by DRL.

Dr Reddys Q4 net up 67% at Rs 571 crore

Last Updated: Tuesday, May 14, 2013, 16:23

Drug firm Dr Reddy's Laboratories on Tuesday reported a 66.58 percent rise in its net profit to Rs 570.89 crore for the quarter ended March 31, 2013 mainly on account of robust sales across all segments.

LIC sells 2.13% stake in Dr Reddy's Lab

Last Updated: Monday, May 13, 2013, 18:53

Life Insurance Corporation (LIC) sold 2.13 percent stake in Dr Reddy's Laboratories from January 10 to May 10 through open market, according to a BSE filing by DRL.

Dr Reddy's Labs recalls muscle relaxant drug from US market

Last Updated: Thursday, April 11, 2013, 16:27

Dr Reddy's Laboratories has initiated recall of its tizanidine tablets, used as a muscle relaxant, from the US market due to labelling issues.